Literature DB >> 17361875

[Arthroscopic treatment of shoulder fractures].

T Bauer1, M Soubeyrand, P Hardy.   

Abstract

Therapeutic options for shoulder joint fractures include conservative treatment or surgery, but indications for either treatment remain vague. Arthroscopic treatment of glenoid fractures and greater tuberosity fractures represents an alternative and allows anatomical reduction and reliable fixation with decreased soft tissue trauma. With this minimally invasive technique, large muscular dissections are avoided and postoperative recovery is shortened. This technique also allows a complete joint inspection and a more accurate diagnosis for associated injuries than conventional imaging methods. Arthroscopy is a useful diagnostic tool that may avoid underestimation of these associated injuries (labrum, rotator cuff tendons, cartilage) and is also helpful for treating these lesions in the same time. However, arthroscopic treatment of shoulder fractures needs a leaming curve depending on surgeon's experience in shoulder arthroscopy. At present, indications for arthroscopic treatment of shoulder fractures are limited to anterior or posterior glenoid rim fractures and some greater tuberosity fractures. This selection is best made using preoperative computed tomography and especially 2D reconstruction.

Entities:  

Mesh:

Year:  2006        PMID: 17361875

Source DB:  PubMed          Journal:  Chir Main        ISSN: 1297-3203


  2 in total

1.  Simultaneous arthroscopic treatment of displaced greater tuberosity and glenoid fracture using a double-row technique.

Authors:  Nicolas Pujol; Olivier Fong; Stephane Scharycki; Julien Remi; Philippe Beaufils; Philippe Boisrenoult
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2009-07-24       Impact factor: 4.342

2.  The feasibility and results of an arthroscopic removal of humeral locking plates and glenohumeral arthrolysis after proximal humeral fractures.

Authors:  Ali Maqdes; Bruno Levy; Shahnaz Klouche; Philippe Hardy
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2013-02-09       Impact factor: 4.342

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.